Product Code: RP-ID-10151886 |
Published Date: 21 Oct 2022 |
Region: Global |
Category: Healthcare & Pharmaceuticals |
Report ID: 10151886
Market Overview:
Global Minimally Invasive Surgical Systems Industry Market Research 2022-2030
"The global minimally invasive surgical systems market is relatively small. The total addressable market in 2021 is estimated to be around USD ~8 billion and is expected to mark a CAGR of ~9% over the period 2022-2030. However, in 2020, robot-assisted surgery accounted for almost 30% of MIS procedures, and now this percentage has risen to more than 35%. Traditional surgical instruments cannot provide high-quality images/videos of the affected area, which causes difficulties in the case of complex surgery. In contrast, robotic surgery makes it easier for surgeons to perform complex operations with relatively small incisions. In addition, robotic surgery can significantly improve the patient's treatment effect and reduce the patient's hospital stay.
MARKET DYNAMICS:
Factors such as increased demand for minimally invasive surgery, increased incidence of chronic diseases, general recognition of computer-assisted surgery, increased disposable income, and the introduction of technologically advanced systems, such as SurgiBot, Amadeus, Single Port Orifice Robotic Technology (SPORT) and Modus V and others are driving the growth of this market. The incidence of colorectal cancer, neurological diseases, interventional heart disease and gynecological diseases is rising, and the elderly population is increasing.
The government and industry participants actively participate in the technological advancement in the field of computer-assisted robotic surgery, which promotes the overall growth of the healthcare industry . In addition, another important factor contributing to the growth of the overall market is the availability of equipment and accessories used in minimally invasive surgery. Surgical robot suppliers generate revenue through the one-time sale of surgical systems, and generate recurring revenue through the sale of equipment and accessories used in the surgical system and maintenance services. Surgical robotic systems are a challenge for market participants to obtain regulatory approvals and permits.
However, recently established participants are working hard to obtain the necessary regulatory permits to enter the market and introduce clinical evidence to increase the adoption rate of surgical systems in the near future. In addition, the world lacks well-trained professionals or surgeons who can easily understand the technical details of these technologically advanced surgical robotic systems, which also hinders the growth of this market. However, industry and government participants from different countries are actively involved in providing training services for surgeons and trying to make them comfortable in terms of use and technology.
END -USER SEGMENTATION :
Hospitals is the application field that contributes the most to revenue. It is expected to grow at a compound annual growth rate of ~13% during the 2022-2030 forecast period. This can be attributed to the continuous demand for minimally invasive Growth surgery.
The participation of government and industry leaders in continuous technological advancement has led to an increasing demand for more advanced robotic surgery systems for medical staff and patients. However, the outpatient part of the surgery center is the second largest end user segment, accounting for 293.7 million US dollars in 2016.
In addition, it is expected to grow at the highest compound annual growth rate of 19% during the 2022-2030 forecast period. This can be attributed to the increasing adoption rate of robotic surgery systems in outpatient surgery centers for various surgical procedures, providing cost-effective services and a less stressful and convenient environment than many hospitals can provide.The participation of government and industry leaders in continuous technological advancement has led to an increasing demand for more advanced robotic surgery systems for medical staff and patients.
However, the outpatient part of the surgery center is the second largest end user segment, accounting for USD 300 million in 2020. In addition, it is expected to grow at the highest compound annual growth rate of 17% during the 2022-2030 forecast period. This can be attributed to the increasing adoption rate of robotic surgery systems in outpatient surgery centers for various surgical procedures, providing cost-effective services and a less stressful and convenient environment than many hospitals can provide."
Related Reports
Proof of Quality & Reliability
